Table 4b.
110 dB SPL noise exposure: Enriched pathways
| Term | Count | Percentage | P |
|---|---|---|---|
| MAPK signaling | 13 | 0.6 | 2.4E-5 |
| Type II diabetes mellitus | 4 | 0.2 | 1.6E-2 |
| Calcium signaling | 7 | 0.3 | 1.8E-2 |
| B cell receptor signaling | 4 | 0.2 | 5.7E-2 |
| Primary immunodeficiency | 3 | 0.1 | 5.9E-2 |
| Fc epsilon RI signaling | 4 | 0.2 | 6.1E-2 |
| Wnt signaling | 5 | 0.2 | 8.0E-2 |
| Fc gamma R-mediated phagocytosis | 4 | 0.2 | 9.2E-2 |